Chennai, March 16 -- Highlights :

* One month course of rifapentine plus isoniazid was comparable to single agent isoniazid treatment for nine months to prevent tuberculosis infection in HIV patients as //per a recent randomized trial

* Preventive therapy, especially in high-risk groups such as HIV infected patients is one of the key strategies to eradicate tuberculosis, but current preventive regimens last for several months and patient compliance is poor

* Tuberculosis remains the leading killer among infections. Despite TB programs achieving reduced death rates and being cost-effective, there has been no noticeable impact on the global incidence of TB

Short one-month regimen of rifapentine plus isoniazid is equally effective in pre...